Can a Montana resident get peptides by telehealth?
MCA 37-2-305 authorizes health care providers licensed in Montana to provide services through telehealth, defines telehealth as audio, video, or other telecommunications technology (including audio-only communication) delivered over a secure connection, and lets each licensing board adopt telehealth rules for its licensees. Under the Board of Medical Examiners' telemedicine rules, a provider-patient relationship may be established by an in-person examination when the standard of care requires one, by consultation with a provider who has a documented relationship with the patient, or through telemedicine when the standard of care does not require an in-person encounter. The prescriber must hold a Montana license. Montana's definition does not separately address questionnaire-only asynchronous prescribing, so this record leaves it unconfirmed. None of the peptides in this database are controlled substances. [2]
How does the Montana pharmacy board treat compounding?
| Board | Montana Board of Pharmacy (Department of Labor and Industry, Business Standards Division) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Montana Board of Pharmacy licenses pharmacies under MCA Title 37, chapter 7, and adopts rules in ARM Title 24, chapter 174. Part 7 of chapter 7 (MCA 37-7-701 and following) requires every out-of-state mail order pharmacy that ships prescriptions to Montana residents to register with the Board, submit a good-standing certificate from its home-state licensing authority, disclose ownership and officers, and identify the home-state pharmacist in charge of dispensing to Montana (MCA 37-7-703; ARM 24.174.1001 and 24.174.1003). Montana has no state bulks list; peptide eligibility follows the federal 503A framework. Montana's sterile compounding standards are in ARM 24.174.841 (sterile products), in subchapter 8 of the Board's rules (pharmacies), which requires compounding pharmacies to keep policies and procedures that comply with the spirit of USP chapters 795 and 797. The Board has proposed amending that rule and adopting new rules on nonsterile compounding, hazardous drug handling, and outsourcing facilities in MAR Notice No. 2026-131 (public hearing August 14, 2026); this record treats those changes as proposals until the Board adopts them. [1] [3] [4] [5] [6] [8]
Can you get compounded GLP-1s in Montana?
Rural Montana patients often rely on mail order; any pharmacy mailing compounded GLP-1s into Montana must be registered as an out-of-state mail order pharmacy under MCA 37-7-703. [3] [11]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Montana?
Verified access options
Prescriber licensed in Montana, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Montana. Whether questionnaire-only prescribing is permitted is not clearly settled, so expect a live visit.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in Montana
Is it legal to buy research peptides in Montana?
The Montana Food, Drug, and Cosmetic Act (MCA Title 50, chapter 31) prohibits selling adulterated or misbranded drugs, and MCA Title 37, chapter 7 restricts dispensing of prescription drugs to licensed pharmacies. [1] [7] [12]
Peptide-specific notes for Montana
No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.
Frequently asked questions
Can I get a GLP-1 prescription in Montana through telehealth?
Yes, from a Montana-licensed prescriber. MCA 37-2-305 authorizes telehealth, including audio-only care, and a relationship may be established through telemedicine when the standard of care does not require an in-person visit. Semaglutide and tirzepatide are not controlled substances. [2]
Does Montana count a phone call as telehealth?
Yes. Montana's statutory definition of telehealth expressly includes audio-only communication over a secure connection, though the prescriber must still meet the standard of care for the condition being treated. [2]
Can an out-of-state pharmacy mail compounded peptides to me in Montana?
Only if it is registered with the Montana Board of Pharmacy as an out-of-state mail order pharmacy under MCA 37-7-703, which requires a home-state good-standing certificate and a named pharmacist in charge of Montana dispensing. [3] [4]
Can a Montana pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]Montana Board of Pharmacy
- [2]MCA 37-2-305, Telehealth services, rulemaking authority
- [3]MCA 37-7-703, Out-of-state mail order pharmacy registration requirements
- [4]ARM 24.174.1001, Registration of out-of-state mail service pharmacies
- [5]ARM 24.174.841, Sterile products
- [6]Montana Board of Pharmacy, MAR Notice No. 2026-131, proposed amendment of ARM 24.174.841 and adoption of compounding rules
- [7]MCA Title 50, chapter 31, Food, drugs, and cosmetics
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [12]21 U.S.C. 331, Prohibited acts
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in Montana?. https://peptideagent.ai/legal/montana- HTML link
<a href="https://peptideagent.ai/legal/montana">Are peptides legal in Montana?</a>, PeptideAgent, updated September 22, 2026.